According to its histological characteristics and expression of estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2), breast cancer can be subdivided into luminal A, luminal B, HER2 overexpression, and triple-negative breast cancer (TNBC), respectively[2,3]. This evidence concerns the gene ERBB2 and breast carcinoma.